Trials / Conditions / Retroperitoneal Fibrosis
Retroperitoneal Fibrosis
7 registered clinical trials studyying Retroperitoneal Fibrosis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics NCT06741423 | Heidelberg University | — |
| Recruiting | Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis NCT04047576 | Peking University International Hospital | Phase 2 / Phase 3 |
| Completed | Treatment of IgG4-Related Disease With Revlimid and Rituximab NCT02705638 | Mayo Clinic | Phase 1 |
| Completed | Rituximab in IgG4-RD: A Phase 1-2 Trial NCT01584388 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Unknown | Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria NCT03133949 | Centre Hospitalier Universitaire, Amiens | — |
| Recruiting | National Registry of Rare Kidney Diseases NCT06065852 | UK Kidney Association | — |
| Unknown | Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis NCT00440349 | University of Parma | Phase 2 |